Decibel Therapeutics Inc DBTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 08/12/22 EDT
4.33UNCH (UNCH)
Volume
25,578
52 week range
1.83 - 8.86
Loading...
  • Open4.30
  • Day High4.40
  • Day Low4.20
  • Prev Close4.33
  • 52 Week High8.86
  • 52 Week High Date09/02/21
  • 52 Week Low1.83
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap108.08M
  • Shares Out24.96M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-6.88

KEY STATS

  • Open4.30
  • Day High4.40
  • Day Low4.20
  • Prev Close4.33
  • 52 Week High8.86
  • 52 Week High Date09/02/21
  • 52 Week Low1.83
  • 52 Week Low Date05/09/22
  • Market Cap108.08M
  • Shares Out24.96M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-6.88

RATIOS/PROFITABILITY

  • EPS (TTM)-2.42
  • P/E (TTM)-1.79
  • Fwd P/E (NTM)-2.16
  • EBITDA (TTM)-51.994M
  • ROE (TTM)-35.65%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.14%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Decibel Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Decibel Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorder. It is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates single-cell genomics and bioinformatics analyses, precision gene...
William Carson M.D.
Independent Chairman of the Board
Laurence Reid Ph.D.
President, Chief Executive Officer, Director
Elisabeth Leiderman M.D.
Chief Financial Officer, Head - Corporate Development, Principal Accounting Officer
Address
1325 Boylston Street, Suite 500
Boston, MA
02215
United States

Top Peers

SYMBOLLASTCHG%CHG
AKUS
Akouos Inc
3.12+0.29+10.25%
CAPR
Capricor Therapeutics Inc
5.00-0.28-5.30%
MGTA
Magenta Therapeutics Inc
1.77+0.04+2.31%
BCLI
Brainstorm Cell Therapeutics Inc
3.50+0.55+18.64%
CRDF
Cardiff Oncology Inc
3.04+0.02+0.66%